Scalable flibanserin nanocrystal-based novel sublingual platform for female hypoactive sexual desire disorder: engineering, optimization adopting the desirability …
MJ Naguib, AIA Makhlouf - Drug Delivery, 2021 - Taylor & Francis
Flibanserin (FLB) was approved by FDA for the treatment of pre-menopausal female
hypoactive sexual desire disorder (HSDD). FLB suffers from low oral bioavailability (33%) …
hypoactive sexual desire disorder (HSDD). FLB suffers from low oral bioavailability (33%) …
RETRACTED: Application of Nanopharmaceutics for Flibanserin Brain Delivery Augmentation Via the Nasal Route
OAA Ahmed, UA Fahmy, SM Badr-Eldin, HM Aldawsari… - Nanomaterials, 2020 - mdpi.com
Flibanserin (FLB) is a nonhormonal medicine approved by the Food and Drug
Administration (FDA) to treat the hypoactive sexual appetite disorder in females. However …
Administration (FDA) to treat the hypoactive sexual appetite disorder in females. However …
RETRACTED: Intranasal Niosomal In Situ Gel as a Promising Approach for Enhancing Flibanserin Bioavailability and Brain Delivery: In Vitro Optimization and Ex Vivo …
UA Fahmy, SM Badr-Eldin, OAA Ahmed, HM Aldawsari… - Pharmaceutics, 2020 - mdpi.com
Flibanserin (FLB) is a multifunctional serotonergic agent that was recently approved by the
FDA for the oral treatment of premenopausal women with hypoactive sexual desire disorder …
FDA for the oral treatment of premenopausal women with hypoactive sexual desire disorder …
Optimized nanostructured lipid carriers integrated into in situ nasal gel for enhancing brain delivery of flibanserin
Background and Aim Flibanserin (FLB) is a multifunctional serotonergic agent used for
treating hypoactive sexual desire disorder in premenopausal women via oral administration …
treating hypoactive sexual desire disorder in premenopausal women via oral administration …
Spanlastics as a potential platform for enhancing the brain delivery of flibanserin: in vitro response-surface optimization and in vivo pharmacokinetics assessment
WS Alharbi, RH Hareeri, M Bazuhair, MA Alfaleh… - Pharmaceutics, 2022 - mdpi.com
Flibanserin was licensed by the United States Food and Drug Administration (FDA) as an
oral non-hormonal therapy for pre-menopausal women with inhibited sexual desire disorder …
oral non-hormonal therapy for pre-menopausal women with inhibited sexual desire disorder …
Design and In Vitro Evaluation of Finasteride-Loaded Liquid Crystalline Nanoparticles for Topical Delivery
In this study, liquid crystalline nanoparticles (LCN) have been proposed as new carrier for
topical delivery of finasteride (FNS) in the treatment of androgenetic alopecia. To evaluate …
topical delivery of finasteride (FNS) in the treatment of androgenetic alopecia. To evaluate …
Pharmaceutical and pharmacological evaluation of the effect of nano-formulated spironolactone and progesterone on inflammation and hormonal levels for managing …
Hirsutism is a dermatological condition that refers to the excessive growth of hair in
androgen-sensitive areas in women. Recently, the enhancement of the visible signs of a …
androgen-sensitive areas in women. Recently, the enhancement of the visible signs of a …
Darifenacin Self-assembled Liquid Crystal Cubic Nanoparticles: a Sustained Release Approach for an Overnight Control of Overactive Bladder
MM Farag, W El-Sebaie, EB Basalious… - AAPS …, 2023 - Springer
The current study is regarding the development and characterization of Darifenacin-loaded
self-assembled liquid crystal cubic nanoparticles (LCCN). An anhydrous approach was used …
self-assembled liquid crystal cubic nanoparticles (LCCN). An anhydrous approach was used …
Innovative berberine nanoethosomal vaginal in situ gel: Unraveling polycystic ovary syndrome treatment on female Wistar rats
S Usulkar, K Sutar, P Biradar, V Patil… - International Journal of …, 2024 - Elsevier
Purpose The present work seeks to develop, assess and refine a nanoethosomal vaginal in
situ gel containing Berberine, aimed at enhancing its efficacy in treating Poly Cystic Ovary …
situ gel containing Berberine, aimed at enhancing its efficacy in treating Poly Cystic Ovary …
Histological assessment of follicular delivery of flutamide by solid lipid nanoparticles: potential tool for the treatment of androgenic alopecia
H Hamishehkar, S Ghanbarzadeh… - Drug development …, 2016 - Taylor & Francis
Context: Flutamide is a potent anti-androgen with the several unwanted side effects in
systemic administration, therefore, it has attracted special interest in the development of …
systemic administration, therefore, it has attracted special interest in the development of …